Mariner LLC Trims Stock Holdings in Integer Holdings Co. (NYSE:ITGR)

Mariner LLC lessened its stake in shares of Integer Holdings Co. (NYSE:ITGR) by 3.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,705 shares of the medical equipment provider’s stock after selling 296 shares during the quarter. Mariner LLC’s holdings in Integer were worth $1,154,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in ITGR. Mather Group LLC. boosted its position in shares of Integer by 304.3% during the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 143 shares during the period. Lee Danner & Bass Inc. acquired a new stake in shares of Integer in the fourth quarter valued at $27,000. R Squared Ltd purchased a new stake in shares of Integer in the 4th quarter valued at $44,000. Sterling Capital Management LLC lifted its stake in Integer by 472.9% during the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider’s stock worth $45,000 after acquiring an additional 279 shares in the last quarter. Finally, Versant Capital Management Inc boosted its holdings in Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after acquiring an additional 183 shares during the period. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently issued reports on ITGR. KeyCorp reduced their price target on shares of Integer from $154.00 to $145.00 and set an “overweight” rating on the stock in a research report on Monday, April 21st. Truist Financial set a $150.00 target price on shares of Integer in a report on Friday. StockNews.com lowered Integer from a “hold” rating to a “sell” rating in a research report on Friday. Benchmark decreased their target price on Integer from $150.00 to $140.00 and set a “buy” rating for the company in a report on Friday. Finally, Raymond James upped their price target on Integer from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Integer has an average rating of “Moderate Buy” and a consensus target price of $145.56.

Integer Stock Performance

Shares of Integer stock opened at $123.39 on Friday. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. Integer Holdings Co. has a 52 week low of $104.93 and a 52 week high of $146.36. The firm’s 50 day moving average is $119.58 and its two-hundred day moving average is $130.26. The firm has a market capitalization of $4.31 billion, a P/E ratio of 36.72, a P/E/G ratio of 1.72 and a beta of 1.09.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $437.39 million for the quarter, compared to analyst estimates of $428.51 million. Research analysts forecast that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.